Company

Huadong Medicine Subsidiary Doer Bio's DR30206 Cleared for Clinical Trials by NMPA – Triple‑Targeting PD‑L1/VEGF/TGF‑β Fusion Protein Advances Against Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Clinical trial approval / initiationDoer Biologics

Huadong Medicine Subsidiary Doer Bio’s DR30206 Cleared for Clinical Trials by NMPA – Triple‑Targeting PD‑L1/VEGF/TGF‑β Fusion Protein Advances Against Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Huadong Medicine Co., Ltd. (SHE: 000963) announced that its controlled subsidiary, Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), has received approval from China's National Medical Products Administration (NMPA) to initiate…

Shanghai Ark Biopharmaceutical's AK0406 Receives FDA IND Clearance for Phase 2 Trial – Long‑Acting Antiviral‑Fc Conjugate Advances Toward Influenza Prevention

Shanghai Ark Biopharmaceutical’s AK0406 Receives FDA IND Clearance for Phase 2 Trial – Long‑Acting Antiviral‑Fc Conjugate Advances Toward Influenza Prevention

T-MAXIMUM's MT027 Wins FDA Clearance for Phase 2 Study – Non‑Viral Allogeneic B7‑H3 CAR‑T Targets Advanced Solid Tumor Brain Metastases

T-MAXIMUM’s MT027 Wins FDA Clearance for Phase 2 Study – Non‑Viral Allogeneic B7‑H3 CAR‑T Targets Advanced Solid Tumor Brain Metastases

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
IPOSHA: 688520

Sinocelltech Files for Hong Kong Secondary Listing to Expand Global Capital Access and Therapeutic Portfolio

HKG: 1302Lifetech Scientific

Lifetech Scientific to Acquire Starway Medical Technology in $276 Million Deal to Expand Structural Heart Portfolio

AIBiocytogen Pharmaceuticals

Biocytogen Launches RenSuper Workstation, AI-Driven Antibody Discovery Platform to Transform Therapeutic Development

Johnson & Johnson MedTech Partners with Beijing Shijitan Hospital to Establish China's First Split-Type Surgical Robot Training Base
Johnson & Johnson MedTech

Johnson & Johnson MedTech Partners with Beijing Shijitan Hospital to Establish China’s First Split-Type Surgical Robot Training Base

Show More